Search Results

Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).

• Authors : Guy S; 414090Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.; Kitchen S

Subjects: COVID-19 Drug Treatment*; Arginine/Arginine/Arginine/*analogs & derivatives ; Partial Thromboplastin Time/Partial Thromboplastin Time/Partial Thromboplastin Time/*methods

• Source: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis [Clin Appl Thromb Hemost] 2021 Jan-Dec; Vol. 27, Publisher: Sage Publications Country of Publication: United States NLM ID: 9508125 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Education Full Text (H.W. Wilson)

Record details

Modeling the effects of bivalirudin in cardiac surgical patients.

• Authors : Edrich T; Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA. ; Frendl G

Subjects: Models, Cardiovascular* ; Partial Thromboplastin Time*; Cardiac Surgical Procedures/Cardiac Surgical Procedures/Cardiac Surgical Procedures/*adverse effects

• Source: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference [Annu Int Conf Publisher: [IEEE] Country of Publication: United States NLM ID: 101763872 Publication Model: Print Cited Medium: Internet ISSN: 2694-0604

Record details

Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance.

• Authors : Eichler P; Institute for Immunology and Transfusion Medicine and Institute for Biometry and Medical Informatics, Ernst-Moritz-Arndt-University, Greifswald, Germany.; Friesen HJ

Subjects: Partial Thromboplastin Time*; Antibodies/Antibodies/Antibodies/*blood ; Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use

• Source: Blood [Blood] 2000 Oct 01; Vol. 96 (7), pp. 2373-8.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Print ISSN: 0006-4971 (Print)

Record details

Risk factors for early fatal outcomes among children with hemophagocytic lymphohistiocytosis (HLH): a single-institution case-series in Vietnam.

• Authors : Dao AT; 1Department of Pediatrics, The University of Medicine and Pharmacy, Ho-Chi-Minh City, Vietnam.; Luong VT

Subjects: Lymphohistiocytosis, Hemophagocytic/Lymphohistiocytosis, Hemophagocytic/Lymphohistiocytosis, Hemophagocytic/*mortality ; Partial Thromboplastin Time/Partial Thromboplastin Time/Partial Thromboplastin Time/*mortality ; Thrombocytopenia/Thrombocytopenia/Thrombocytopenia/*mortality

• Source: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2014 Apr; Vol. 31 (3), pp. 271-81. Date of Electronic Publication: 2013 Dec 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab.

• Authors : Nusrat, Sanober¹ (AUTHOR) ; Tewari, Sayani² (AUTHOR); Khan, Osman³ (AUTHOR)

Subjects: *RITUXIMAB; *PARTIAL thromboplastin time; *ANTIPHOSPHOLIPID syndrome

• Source: Thrombosis Journal. 7/17/2023, Vol. 21, p1-4. 4p.

Record details

Anticoagulation Management for Veno-Venous ECMO in COVID-19 Patients: Argatroban as Rescue Therapy in Heparin-Associated Thrombocytopenia.

• Authors : Schiavoni, Lorenzo¹ (AUTHOR) ; Mattei, Alessia¹ (AUTHOR) ; Cuccarelli, Martina¹ (AUTHOR)

Subjects: *PARTIAL thromboplastin time; *ADULT respiratory distress syndrome; *EXTRACORPOREAL membrane oxygenation

• Source: Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 22, p6984. 14p.

Record details

Responsiveness of the activated partial thromboplastin time and dilute thrombin time to argatroban: Results of an in vitro study.

• Authors : Scalambrino, Erica; Padovan, Lidia; Chantarangkul, Veena

Subjects: ANTICOAGULANTS; BLOOD coagulation; BLOOD collection

• Source: International Journal of Laboratory Hematology. Jun2020, Vol. 42 Issue 3, pe128-e131. 4p.

Record details

Association of Lumbar Puncture With Spinal Hematoma in Patients With and Without Coagulopathy.

• Authors : Bodilsen, Jacob; Mariager, Theis; Vestergaard, Hannah Holm

Subjects: PARTIAL thromboplastin time; SPINE diseases; HEMATOMADENMARK

• Source: JAMA: Journal of the American Medical Association. 10/13/2020, Vol. 324 Issue 14, p1419-1428. 10p.

Record details

Prolonged coagulation times in severe fever with thrombocytopenia syndrome virus infection, the indicators of heparin‐like effect and increased haemorrhagic risk.

• Authors : Tang, Ning¹ (AUTHOR) ; Yuan, Peihong¹ (AUTHOR); Luo, Ming¹ (AUTHOR)

Subjects: *PARTIAL thromboplastin time; *VIRUS diseases; *BLOOD coagulation

• Source: British Journal of Haematology. May2024, Vol. 204 Issue 5, p1999-2006. 8p.

Record details